SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
27 hedge funds and large institutions have $62.9M invested in scPharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
5
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$704K |
| 2 |
EP
Eversept Partners
New York
|
+$453K |
| 3 |
Squarepoint
New York
|
+$310K |
| 4 |
Renaissance Technologies
New York
|
+$292K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18K |
Top Sellers
| 1 |
Northern Trust
Chicago,
Illinois
|
-$62K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$60K |
| 3 |
JPMorgan Chase & Co
New York
|
-$48.9K |
| 4 |
Morgan Stanley
New York
|
-$28.6K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$27.1K |
